- Will ProText Mobility, Inc. (OTCQB: TXTM) Find a Way to Monetize Applications for Mobile Communications Market?
- Can Tranzbyte Corporation (PINKSHEETS: ERBB) Overcome Concerns Surrounding Marijuana Business?
- SoundBite Communications (NASDAQ: SDBT) Surges Following Acquisition Agreement
- Is Regenerative Medicine Realistic for YaFarm Technologies (PINKSHEETS: YFRM)?
- Can Raptor Pharmaceutical Corp. (NASDAQ: RPTP) Turn FDA Approval into Big Payday Down the Road?
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tagsaapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks trading
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: biotechnology
Can Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) Advance Projects of Regen BioPharma to Clinical Trials?
The massive trading volume that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has attracted over the past few months has taken even greater heights on Monday as the biotechnology company focused on the development of regenerative medicine therapies and tools to … Continue reading
Will Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) Ease Investor Concern with Reported Progress of Subsidiary?
Few companies in the penny stock market have attracted the kind of attention that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has over the past week and on Friday that attention hit a new level with more than 121 million shares … Continue reading
It would be safe to say that several investors have lost a considerable amount of sleep, as well as money, in their dealings with Dendreon Corp. (NASDAQ: DNDN) as the biotechnology company has hit highs near the $60 level while … Continue reading
For a company that hasn’t issued a press release since April 30, 2012 there has been a tremendous amount of interest in Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) as the biotechnology company has seen massive trading volume and Friday has … Continue reading
Can Inovio Pharmaceuticals, Inc. (AMEX: INO) Realize Potential with Multiple Synthetic Vaccines for Wide Range of Medical Issues?
After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading
Does Amarantus BioSciences, Inc. (OTCBB: AMBS) Have the Inside Track for New Treatments for Parkinson’s and Alzheimer’s?
Amarantus BioSciences, Inc. (OTCBB: AMBS) is positioning itself to close the week on a high note as the biotechnology company that develops new treatments and diagnostics for Parkinson’s disease and Traumatic Brain Injury centered on their proprietary anti-apoptotis therapeutic protein … Continue reading
Is Northwest Biotherapeutics (OTCQB: NWBO) Finally Catching the Attention of Investors with Advancement of Cancer Therapy?
While shares of Northwest Biotherapeutics (OTCQB: NWBO) haven’t quite reached the same levels they were at a year ago it appears as if investors are encouraged by the recent advancements the biotechnology company has made and trading activity has reflected … Continue reading
One year ago shares of Dendreon Corp. (NASDAQ: DNDN) were trading at a 52-week high of 37.19 and the darling of the biotechnology industry with a prostate cancer drug on the market that was almost certainly going to bring in … Continue reading
Does BrainStorm Cell Therapeutics (OTCBB: BCLI) Have What it Takes to Halt ALS with Stem Cell Treatment?
While BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) announced on Tuesday their intention to sell 19.8 million shares of their common stock at 29 cents each, effectively raising an estimated $4.78 million, investors found little reason to ignite a buying frenzy … Continue reading
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) Pushing Cancer Treatment Forward, Investors Await ASCO Presentation
After a slow start to the month in which they hit a low of 2.05 shares of ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) have been on strong run as the biotechnology company focused on the development of novel immune-based cancer therapies … Continue reading